CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving treatment outcomes for children with high-risk brain tumors by developing targeted therapies using oncolytic adenoviruses. The research aims to enhance the immune response against tumors, potentially leading to better prognoses and quality of life for affected patients.
The overreaching goal of my lab is to improve the prognosis of patients with high-risk pediatric brain tumors.
To this end, I propose to integrate clinical and lab-based research to develop tumor-targeted oncolytic adenoviruses with the capacity to elicit a therapeutic immune response in those tumors.
Our research will use novel and relevant models to accomplish the experimental aims.
We have previously worked with Delta-24-RGD (DNX-2401) a replication-competent adenovirus that has been translat…
UNIVERSIDAD DE NAVARRA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
